| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial
|
Mulenga, Veronica
|
|
2016
|
16 |
2 |
p. 169-179
11 p.
|
artikel
|
| 2 |
Alternatives to antibiotics—a pipeline portfolio review
|
Czaplewski, Lloyd
|
|
2016
|
16 |
2 |
p. 239-251
13 p.
|
artikel
|
| 3 |
A new mosquito-borne threat to pregnant women in Brazil
|
Triunfol, Marcia
|
|
2016
|
16 |
2 |
p. 156-157
2 p.
|
artikel
|
| 4 |
Artemisinin-based combination therapy for knowlesi malaria
|
Ramharter, Michael
|
|
2016
|
16 |
2 |
p. 134-136
3 p.
|
artikel
|
| 5 |
Artesunate–mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trial
|
Grigg, Matthew J
|
|
2016
|
16 |
2 |
p. 180-188
9 p.
|
artikel
|
| 6 |
Changing hepatitis B virus epidemiology in rural China
|
Zhou, Yi-Hua
|
|
2016
|
16 |
2 |
p. 150-151
2 p.
|
artikel
|
| 7 |
Changing hepatitis B virus epidemiology in rural China
|
Ott, Jördis J
|
|
2016
|
16 |
2 |
p. 150-
1 p.
|
artikel
|
| 8 |
Changing hepatitis B virus epidemiology in rural China – Authors' reply
|
Liu, Min
|
|
2016
|
16 |
2 |
p. 151-152
2 p.
|
artikel
|
| 9 |
CHAPAS-3 fills the gap
|
Moultrie, Harry
|
|
2016
|
16 |
2 |
p. 133-134
2 p.
|
artikel
|
| 10 |
Chronic skin ulcers in a patient returning from Mexico
|
Weitzel, Thomas
|
|
2016
|
16 |
2 |
p. 264-
1 p.
|
artikel
|
| 11 |
Colistin resistance: a major breach in our last line of defence
|
Paterson, David L
|
|
2016
|
16 |
2 |
p. 132-133
2 p.
|
artikel
|
| 12 |
Corrections
|
|
|
2016
|
16 |
2 |
p. 143-
1 p.
|
artikel
|
| 13 |
Corrections
|
|
|
2016
|
16 |
2 |
p. 143-
1 p.
|
artikel
|
| 14 |
Dissemination of the mcr-1 colistin resistance gene
|
Webb, Hattie E
|
|
2016
|
16 |
2 |
p. 144-145
2 p.
|
artikel
|
| 15 |
Dissemination of the mcr-1 colistin resistance gene
|
Hu, Yongfei
|
|
2016
|
16 |
2 |
p. 146-147
2 p.
|
artikel
|
| 16 |
Dissemination of the mcr-1 colistin resistance gene
|
Arcilla, Maris S
|
|
2016
|
16 |
2 |
p. 147-149
3 p.
|
artikel
|
| 17 |
Dissemination of the mcr-1 colistin resistance gene
|
Olaitan, Abiola Olumuyiwa
|
|
2016
|
16 |
2 |
p. 147-
1 p.
|
artikel
|
| 18 |
Dissemination of the mcr-1 colistin resistance gene
|
Tse, Herman
|
|
2016
|
16 |
2 |
p. 145-146
2 p.
|
artikel
|
| 19 |
Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study
|
Nguipdop-Djomo, Patrick
|
|
2016
|
16 |
2 |
p. 219-226
8 p.
|
artikel
|
| 20 |
Ebola: lessons learned and future challenges for Europe
|
Quaglio, GianLuca
|
|
2016
|
16 |
2 |
p. 259-263
5 p.
|
artikel
|
| 21 |
Efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trial
|
Olveda, Remigio M
|
|
2016
|
16 |
2 |
p. 199-208
10 p.
|
artikel
|
| 22 |
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
|
Liu, Yi-Yun
|
|
2016
|
16 |
2 |
p. 161-168
8 p.
|
artikel
|
| 23 |
Ethiopia shows it is single-minded in tackling disease
|
Burki, Talha
|
|
2016
|
16 |
2 |
p. 153-154
2 p.
|
artikel
|
| 24 |
Guinea worm disease nears eradication
|
The Lancet Infectious Diseases,
|
|
2016
|
16 |
2 |
p. 131-
1 p.
|
artikel
|
| 25 |
Infection disease surveillance update
|
Zwizwai, Ruth
|
|
2016
|
16 |
2 |
p. 157-
1 p.
|
artikel
|
| 26 |
Interventions to reduce zoonotic and pandemic risks from avian influenza in Asia
|
Peiris, J S Malik
|
|
2016
|
16 |
2 |
p. 252-258
7 p.
|
artikel
|
| 27 |
Long-term protectiveness of BCG
|
Sotgiu, Giovanni
|
|
2016
|
16 |
2 |
p. 140-142
3 p.
|
artikel
|
| 28 |
New therapeutic agents for chronic hepatitis B
|
Brahmania, Mayur
|
|
2016
|
16 |
2 |
p. e10-e21
nvt p.
|
artikel
|
| 29 |
Plasmid-mediated colistin resistance mechanisms: is it time to revise our approach to selective digestive decontamination?
|
Rawson, Timothy Miles
|
|
2016
|
16 |
2 |
p. 149-150
2 p.
|
artikel
|
| 30 |
Pyronaridine-artesunate retreatment for malaria
|
Bélard, Sabine
|
|
2016
|
16 |
2 |
p. 136-137
2 p.
|
artikel
|
| 31 |
Research brief
|
Mohammadi, Dara
|
|
2016
|
16 |
2 |
p. 158-
1 p.
|
artikel
|
| 32 |
Respiratory co-morbidities in people with HIV
|
Smit, Mikaela
|
|
2016
|
16 |
2 |
p. 152-
1 p.
|
artikel
|
| 33 |
Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial
|
Sagara, Issaka
|
|
2016
|
16 |
2 |
p. 189-198
10 p.
|
artikel
|
| 34 |
Salmonella: no respect for human boundaries
|
Morgan, Jules
|
|
2016
|
16 |
2 |
p. 159-160
2 p.
|
artikel
|
| 35 |
Tackling neglect: treating schistosomiasis in pregnancy
|
Luty, Adrian J F
|
|
2016
|
16 |
2 |
p. 137-139
3 p.
|
artikel
|
| 36 |
The skin as an orchestrator of influenza immunity
|
Stein, Pamela
|
|
2016
|
16 |
2 |
p. 139-140
2 p.
|
artikel
|
| 37 |
The transmission of Mycobacterium tuberculosis in high burden settings
|
Yates, Tom A
|
|
2016
|
16 |
2 |
p. 227-238
12 p.
|
artikel
|
| 38 |
Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial
|
Hung, Ivan Fan-Ngai
|
|
2016
|
16 |
2 |
p. 209-218
10 p.
|
artikel
|
| 39 |
Treatment of visceral leishmaniasis: options and choice
|
Bhattacharya, Sujit K
|
|
2016
|
16 |
2 |
p. 142-143
2 p.
|
artikel
|
| 40 |
WHO estimates suggest large herpes simplex virus burden
|
Bagcchi, Sanjeet
|
|
2016
|
16 |
2 |
p. 155-
1 p.
|
artikel
|
Tijdschrift beschrijving